Co-Authors
This is a "connection" page, showing publications co-authored by Ian Dunn and Christopher Graffeo.
Connection Strength
4.497
-
Pitch Perfect: Clinical Research Primer on the Art of Pitching Projects for Medical Students. J Neurol Surg Rep. 2026 Jan; 87(1):e19-e23.
Score: 0.248
-
Intracranial Retrograde Cerebrospinal Fluid Dissemination of H3?K27-altered Glioma. J Neurol Surg Rep. 2026 Jan; 87(1):e1-e5.
Score: 0.247
-
Correction to: Efficacy and safety of BRAF-MEK dual inhibition in BRAF-V600E mutated papillary craniopharyngioma: a systematic review. J Neurooncol. 2025 Nov 19; 176(1):90.
Score: 0.244
-
Efficacy and safety of BRAF-MEK dual inhibition in BRAF-V600E mutated papillary craniopharyngioma: a systematic review. J Neurooncol. 2025 Oct 30; 176(1):58.
Score: 0.243
-
Exploring the Diagnostic Test Accuracy of MicroRNAs as Potential Biomarkers for Glioblastoma: Systematic Review and Meta-Analysis. Neurosurgery. 2025 Oct 23.
Score: 0.243
-
A systematic review of clinical features of intradiploic epidermoid cysts and strategies for patient management. Neurosurg Rev. 2025 Sep 12; 48(1):639.
Score: 0.241
-
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines Update for the Role of Imaging in the Management of Patients With Vestibular Schwannomas. Neurosurgery. 2025 Jun 05.
Score: 0.237
-
Clinical Research Primer for Medical Students: Behind the Curtain, a Framework on Peer Review for Trainees. J Neurol Surg Rep. 2025 Jan; 86(1):e45-e49.
Score: 0.234
-
Mask-based vs. frame-based stereotactic radiosurgery: A systematic review. J Clin Neurosci. 2025 May; 135:111195.
Score: 0.233
-
Hemilingual spasm treated with microvascular decompression of the posterior inferior cerebellar artery: illustrative case. J Neurosurg Case Lessons. 2025 Mar 24; 9(12).
Score: 0.233
-
GSTM1 null genotype underpins recurrence of NF2 meningiomas. Front Oncol. 2024; 14:1506708.
Score: 0.229
-
Mixed Gangliocytoma-Pituitary Adenoma: A Systematic Review of Diagnostic Features, Clinical Management, and Surgical Outcomes. World Neurosurg. 2024 Nov 13; 193:754-769.
Score: 0.228
-
In Reply to the Letter to the Editor Regarding "Genetically Distinct Oligosarcoma Arising from Oligodendroglioma: Systematic Review & Illustrative Case Example". World Neurosurg. 2024 Sep; 189:553.
Score: 0.224
-
Clinical Research Primer for Medical Students: Overview and Illustrative Experiences. J Neurol Surg Rep. 2024 Apr; 85(2):e88-e95.
Score: 0.221
-
The Eyelid Trans-orbital Trans-cavernous Approach to the Basilar Apex: A Cadaveric Proof-of-Concept Study. J Neurol Surg B Skull Base. 2025 Jun; 86(3):325-331.
Score: 0.220
-
Genetically Distinct Oligosarcoma Arising from Oligodendroglioma: Systematic Review & Illustrative Case Example. World Neurosurg. 2024 Mar 13.
Score: 0.217
-
Decision-Making in Clival Mass Lesions: Risk Factors for Malignant Disease and an Illustrative Case Example. J Neurol Surg Rep. 2023 Oct; 84(4):e156-e162.
Score: 0.214
-
An institutional experience in applying quality improvement measures to pituitary surgery: clinical and resource implications. Neurosurg Focus. 2023 Dec; 55(6):E10.
Score: 0.213
-
Anatomical Step-by-Step Dissection of Complex Skull Base Approaches for Trainees: Lateral Supraorbital Approach with Expanded Indications. J Neurol Surg B Skull Base. 2024 Dec; 85(6):587-595.
Score: 0.212
-
Comparing Isocitrate Dehydrogenase Inhibitors with Procarbazine, Lomustine, and Vincristine Chemotherapy for Oligodendrogliomas. Cancers (Basel). 2025 Dec 04; 17(23).
Score: 0.061
-
Novel Eyelid Supraorbital Pretemporal Approach to the Anterior Communicating Artery Complex: A Quantitative Cadaveric Comparative Study. J Neurol Surg B Skull Base. 2025 Aug; 86(4):471-479.
Score: 0.055